NSG mice were implanted with a mixture of human peripheral blood mononuclear cells (hPBMCs) and human melanoma A2058 cells, followed by local CpG-Stat3 siRNA injection or systemic PD-1 antibody treatment, alone or in combination. The gene discussed is STAT3; the disease is melanoma.